Castle Biosciences CSTL
$32.86 −$0.55 (-1.63%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.86 0.00%
Open$32.76
Prev close$33.41
Day range$32.54 – $33.38
Volume309.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$102.89M+23.9% YoY
Operating profit-$2.73M+59.9% YoY
Net profit-$4.10M-718.4% YoY
Diluted EPS-$0.13-550.0% YoY
Free cash flow$12.25M+57.1% YoY
Operating cash flow$19.74M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin77.1%
Operating margin-7.4%
Net margin-6.1%
Return on equity-4.9%
Return on assets-4.0%
Return on invested capital-5.7%
Current ratio5.28
Liabilities / assets17.4%
Cash & investments$277.67M
Total debt$34.93M
Net cash (debt)$242.74M
Free cash flow / sales1.1%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $102.89M | $103.55M | $83.68M | $344.23M | $87.01M |
| Total Operating Revenue | $102.89M | $103.55M | $83.68M | $344.23M | $87.01M |
| Cost of Revenue | $23.92M | $23.70M | $20.53M | $71.03M | $18.32M |
| Gross Profit | $78.97M | $79.85M | $63.15M | $273.20M | $68.70M |
| Operating Expense | $81.70M | $82.92M | $81.55M | $316.01M | $72.52M |
| Selling and Admin Expenses | $63.23M | $66.12M | $64.90M | $229.32M | $58.07M |
| -Selling & Marketing Expense | $37.68M | $40.92M | $41.04M | $138.12M | $33.40M |
| -General & Admin Expense | $25.56M | $25.21M | $23.86M | $91.21M | $24.67M |
| Research & Development | $15.81M | $14.54M | $14.43M | $51.85M | $13.52M |
| Depreciation & Amortization & Depletion | $2.66M | $2.25M | $2.23M | $34.84M | $939,000.00 |
| -Depreciation & Amortization | $2.66M | $2.25M | $2.23M | $34.84M | $939,000.00 |
| Operating Profit | -$2.73M | -$3.07M | -$18.41M | -$42.81M | -$3.83M |
| Net Non-Operating Interest Income (Expense) | $2.32M | $2.16M | $2.41M | $11.69M | $2.87M |
| Non-Operating Interest Income | $2.51M | $2.36M | $2.55M | $11.77M | $2.90M |
| Non-Operating Interest Expense | $197,000.00 | $193,000.00 | $134,000.00 | $86,000.00 | $24,000.00 |
| Other Income (Expense) | -$3.39M | -$783,000.00 | $1.58M | $1.61M | -$1.76M |
| Gain on Sale of Security | -$3.43M | -$630,000.00 | $2.02M | $1.47M | -$1.86M |
| Other Non-Operating Income (Expenses) | $39,000.00 | -$153,000.00 | -$439,000.00 | $144,000.00 | $96,000.00 |
| Pretax Profit | -$3.80M | -$1.69M | -$14.41M | -$29.51M | -$2.71M |
| Tax | $298,000.00 | $370,000.00 | $109,000.00 | -$5.36M | -$382,000.00 |
| Net Profit | -$4.10M | -$2.06M | -$14.52M | -$24.16M | -$2.33M |
| Profit from Continuing Operations | -$4.10M | -$2.06M | -$14.52M | -$24.16M | -$2.33M |
| Net Income to Parent Company | -$4.10M | -$2.06M | -$14.52M | -$24.16M | -$2.33M |
| Net Income to Common Stockholders | -$4.10M | -$2.06M | -$14.52M | -$24.16M | -$2.33M |
| Basic EPS | -$0.13 | -$0.07 | -$0.49 | -$0.83 | -$0.08 |
| Diluted EPS | -$0.13 | -$0.07 | -$0.49 | -$0.83 | -$0.08 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $579.41M | $561.18M | $547.81M | $578.56M | $578.56M |
| Total Current Assets | $356.86M | $341.10M | $328.90M | $361.10M | $361.10M |
| Cash and Cash Equivalents & Short-Term Investments | $277.67M | $266.81M | $261.69M | $299.51M | $299.51M |
| -Cash and Cash Equivalents | $77.99M | $62.12M | $63.76M | $116.73M | $116.73M |
| -Short Term Investments | $199.67M | $204.69M | $197.92M | $182.78M | $182.78M |
| Receivables | $52.10M | $48.34M | $42.26M | $43.38M | $43.38M |
| -Accounts Receivable | $52.10M | $48.34M | $42.26M | $43.38M | $43.38M |
| Inventory | $10.38M | $10.58M | $10.46M | $10.25M | $10.25M |
| Other Current Assets | $16.71M | $15.37M | $14.49M | $7.96M | $7.96M |
| Total Non-Current Assets | $222.55M | $220.08M | $218.90M | $217.46M | $217.46M |
| Net PPE | $125.43M | $118.88M | $115.36M | $112.24M | $112.24M |
| -Gross PPE | $149.11M | $140.52M | $135.22M | $130.54M | $130.54M |
| -Accumulated Depreciation | -$23.68M | -$21.64M | -$19.86M | -$18.30M | -$18.30M |
| Non Current Accounts Receivables | $1.26M | $1.66M | $1.92M | $1.88M | $1.88M |
| Goodwill and Other Intangible Assets | $91.49M | $95.10M | $97.35M | $99.57M | $99.57M |
| -Goodwill | $10.69M | $10.70M | $10.70M | $10.69M | $10.69M |
| -Other Intangible Assets | $80.80M | $84.40M | $86.65M | $88.88M | $88.88M |
| Other Non-Current Assets | $4.36M | $4.44M | $4.28M | $3.77M | $3.77M |
| Total Liabilities | $100.96M | $91.15M | $86.39M | $107.68M | $107.68M |
| Total Current Liabilities | $67.61M | $56.51M | $48.76M | $68.68M | $68.68M |
| Payables | $19.07M | $14.26M | $15.04M | $18.71M | $18.71M |
| -Accounts Payable | $13.23M | $9.67M | $15.04M | $18.71M | $18.71M |
| -Total Tax Payable | $5.84M | $4.59M | – | – | – |
| Current Accrued Expenses | $6.69M | $6.39M | $6.73M | $5.89M | $5.89M |
| Short-Term Debt and Capital Lease Obligation | $5.81M | $4.33M | $2.92M | $1.74M | $1.74M |
| -Current Debt | $4.17M | $2.92M | $1.67M | $417,000.00 | $417,000.00 |
| -Current Capital Lease Obligation | $1.64M | $1.42M | $1.25M | $1.33M | $1.33M |
| Other Current Liabilities | $2.12M | $3.50M | $4.67M | $3.13M | $3.13M |
| Total Non-Current Liabilities | $33.35M | $34.64M | $37.63M | $39.01M | $39.01M |
| Long Term Debt and Capital Lease Obligation | $30.76M | $32.32M | $33.80M | $35.17M | $35.17M |
| -Long Term Debt | $5.92M | $7.16M | $8.40M | $9.64M | $9.64M |
| -Long Term Capital Lease Obligation | $24.85M | $25.16M | $25.40M | $25.53M | $25.53M |
| Non-Current Deferred Liabilities | $2.40M | $2.32M | $2.33M | $2.34M | $2.34M |
| Other Non-Current Liabilities | $191,000.00 | – | $1.50M | $1.50M | $1.50M |
| Total Equity | $478.44M | $470.03M | $461.42M | $470.87M | $470.87M |
| Stockholders' Equity | $478.44M | $470.03M | $461.42M | $470.87M | $470.87M |
| Capital Stock | $31,000.00 | $31,000.00 | $30,000.00 | $30,000.00 | $30,000.00 |
| -Common Stock | $31,000.00 | $31,000.00 | $30,000.00 | $30,000.00 | $30,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $723.87M | $711.12M | $700.26M | $694.86M | $694.86M |
| Retained Earnings | -$244.97M | -$240.87M | -$238.81M | -$224.28M | -$224.28M |
| Gains/Losses Not Affecting Retained Earnings | -$492,000.00 | -$256,000.00 | -$63,000.00 | $267,000.00 | $267,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $19.74M | $15.20M | -$22.13M | $64.35M | $26.93M |
| Net cash flow from continuing operations | $19.74M | $15.20M | -$22.13M | $64.35M | $26.93M |
| Net Income from Continuing Operations | -$4.10M | -$2.06M | -$14.52M | -$24.16M | -$2.33M |
| Depreciation & Depletion & Amortization | $4.18M | $4.07M | $3.93M | $40.77M | $3.78M |
| Deferred Tax | $76,000.00 | -$3,000.00 | -$10,000.00 | -$6.23M | -$907,000.00 |
| Other Non-Cash Items | $139,000.00 | $235,000.00 | $532,000.00 | $153,000.00 | -$129,000.00 |
| Change in Working Capital | $5.13M | $1.13M | -$19.36M | $13.60M | $13.97M |
| -Change in Receivables | -$3.36M | -$5.82M | $1.08M | $6.88M | $6.27M |
| -Change in Inventory | $199,000.00 | -$119,000.00 | -$207,000.00 | -$2.14M | -$1.60M |
| -Change in Prepaid Assets | -$1.29M | -$877,000.00 | -$6.67M | -$544,000.00 | $3.99M |
| -Change in Payables and Accrued Expense | $9.21M | $8.03M | -$13.23M | $9.68M | $5.48M |
| -Change in Other Current Assets | $294,000.00 | -$30,000.00 | -$159,000.00 | $1.01M | $44,000.00 |
| -Change in Other Current Liabilities | $85,000.00 | -$59,000.00 | -$172,000.00 | -$1.28M | -$209,000.00 |
| Net cash flow from investing | -$4.73M | -$15.96M | -$25.80M | -$60.37M | $8.83M |
| Net Cash Flow from Continuing Investing Activities | -$4.73M | -$15.96M | -$25.80M | -$60.37M | $8.83M |
| Net PPE Purchase and Sale | -$7.48M | -$8.64M | -$12.45M | -$35.98M | -$7.18M |
| Net Investment Purchase and Sale | $2.76M | -$7.32M | -$13.36M | $2.02M | $23.69M |
| Financing Cash Flow | $866,000.00 | -$886,000.00 | -$5.03M | -$6.96M | -$4.59M |
| Net Cash Flow from Continuing Financing Activities | $866,000.00 | -$886,000.00 | -$5.03M | -$6.96M | -$4.59M |
| Net Issuance Payments Of Debt | -$26,000.00 | -$24,000.00 | -$24,000.00 | $75,000.00 | -$27,000.00 |
| Proceeds from Stock Option Exercised | $1.82M | $931,000.00 | $1.59M | $4.62M | $2.81M |
| Net Other Financing Charges | -$923,000.00 | -$1.79M | -$6.60M | -$11.66M | -$7.37M |
| Ending Cash Balance | $77.99M | $62.12M | $63.76M | $116.73M | $116.73M |
| Net Change in Cash | $15.88M | -$1.65M | -$52.97M | -$2.98M | $31.17M |
| Beginning Cash Balance | $62.12M | $63.76M | $116.73M | $119.71M | $85.56M |
| Free Cash Flow | $12.25M | $6.55M | -$34.58M | $28.33M | $19.75M |
| Gain/Loss from Continuing Operations | – | – | -$2.02M | -$1.47M | – |
| Net Business Purchase and Sale | – | – | – | -$18.73M | – |
| Net Other Investing Changes | – | – | – | -$7.68M | $11.04M |
No comments yet — be the first to weigh in on CSTL.
Sign in to join the discussion.